| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 2041.12 | 1405.82 | 898.87 | 536.94 | 377.50 | 271.47 | 135.74 |
| Depreciation & Amort ($Mil): | 33.97 | 33.97 | 28.15 | 18.54 | 14.32 | 10.82 | 5.54 |
| Operating Income ($Mil): | 625.58 | 425.12 | 174.69 | 83.58 | 42.72 | -2.64 | -36.21 |
| Net Income ($Mil): | -1309.08 | 226.43 | 68.98 | 63.65 | 52.75 | -100.00 | -100.00 |
| Earnings Per Share ($): | -3.25 | 0.54 | 0.17 | 0.17 | 0.16 | 0.04 | -0.32 |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | N/C | 3084.42 | 2311.00 | 972.83 | 849.88 | 730.09 | 296.09 |
| Current Liabilities ($Mil): | N/C | 432.93 | 239.70 | 135.63 | 141.41 | 71.79 | 44.28 |
| Long Term Debt ($Mil): | N/C | 0.00 | 0.00 | 0.00 | 400.00 | 0.00 | 0.00 |
| Shares Outstanding (000): | 454880 | 386000 | 372440 | 339220 | 329260 | 324950 | 314800 |
| Common Equity ($Mil): | 3588.36 | 2843.94 | 1976.17 | 635.77 | 477.44 | 310.05 | 276.69 |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -64.14 | 16.11 | 7.67 | 11.85 | 13.97 | 4.98 | -73.67 |
| Return on Equity (%): | 18.05 | 7.96 | 3.49 | 10.01 | 11.05 | 4.36 | -36.14 |
| Return on Assets (%): | 15 | 6.27 | 2.52 | 5.11 | 4.76 | 1.71 | -30.55 |
| P/E Ratio: | 45 | 110.83 | 257.82 | 128.65 | 82.38 | 210.50 | 0.00 |
| Price/Book: | 7 | 8.12 | 8.26 | 11.67 | 9.09 | 8.82 | 0.00 |
| Debt Equity: | 0.00 | 0.00 | 0.00 | 0.00 | 0.84 | 0.00 | 0.00 |
| Interest Coverage: | 129.15 | 47.49 | 22.56 | 9.87 | 7.61 | 3.38 | -5053.50 |
| Book Value ($): | 7.89 | 7.37 | 5.31 | 1.87 | 1.45 | 0.95 | 0.88 |
| Price/Sales: | 17.25 | 12.83 | 18.16 | 13.82 | 11.50 | 10.08 | 0.00 |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |


| AMGEN INC. | +9.80 | 56.34 | |
| GILEAD SCIENCES | -3.90 | 45.22 | |
| CELGENE CORPORA | -10.10 | 57.57 | |
| STEMCELLS INC. | -61.50 | 1.13 | |
| BIOGEN IDEC INC | -30.40 | 43.80 |
